266 related articles for article (PubMed ID: 31251848)
1. Hyams grading as a predictor of metastasis and overall survival in esthesioneuroblastoma: a meta-analysis.
Goshtasbi K; Abiri A; Abouzari M; Sahyouni R; Wang BY; Tajudeen BA; Hsu FPK; Cadena G; Kuan EC
Int Forum Allergy Rhinol; 2019 Sep; 9(9):1054-1062. PubMed ID: 31251848
[TBL] [Abstract][Full Text] [Related]
2. [New system combining Hyams grading system and modified Kadish stage to evaluate the progress of esthesioneuroblastoma].
Lai YY; Lin TJ; Jiang LJ; Deng J; Zuo KJ; Zhang Y; Shi JB
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Jul; 33(7):599-602. PubMed ID: 31327194
[No Abstract] [Full Text] [Related]
3. Consolidating the Hyams grading system in esthesioneuroblastoma - an individual participant data meta-analysis.
Vuong HG; Ngo TNM; Dunn IF
J Neurooncol; 2021 May; 153(1):15-22. PubMed ID: 33770323
[TBL] [Abstract][Full Text] [Related]
4. Esthesioneuroblastoma and sinonasal undifferentiated carcinoma: impact of histological grading and clinical staging on survival and prognosis.
Miyamoto RC; Gleich LL; Biddinger PW; Gluckman JL
Laryngoscope; 2000 Aug; 110(8):1262-5. PubMed ID: 10942123
[TBL] [Abstract][Full Text] [Related]
5. Prognostic utility of Hyams histological grading and Kadish-Morita staging systems for esthesioneuroblastoma outcomes.
Bell D; Saade R; Roberts D; Ow TJ; Kupferman M; DeMonte F; Hanna EY
Head Neck Pathol; 2015 Mar; 9(1):51-9. PubMed ID: 24806334
[TBL] [Abstract][Full Text] [Related]
6. Esthesioneuroblastoma: updating histologic grading as it relates to prognosis.
Gallagher KK; Spector ME; Pepper JP; McKean EL; Marentette LJ; McHugh JB
Ann Otol Rhinol Laryngol; 2014 May; 123(5):353-8. PubMed ID: 24668054
[TBL] [Abstract][Full Text] [Related]
7. Esthesioneuroblastoma: a meta-analysis and review.
Dulguerov P; Allal AS; Calcaterra TC
Lancet Oncol; 2001 Nov; 2(11):683-90. PubMed ID: 11902539
[TBL] [Abstract][Full Text] [Related]
8. Microvessel density and Ki-67 labeling index in esthesioneuroblastoma: is there a prognostic role?
Singh L; Ranjan R; Madan R; Arava SK; Deepak RK; Singh MK
Ann Diagn Pathol; 2015 Dec; 19(6):391-6. PubMed ID: 26343569
[TBL] [Abstract][Full Text] [Related]
9. Long-term oncologic outcomes in esthesioneuroblastoma: An institutional experience of 143 patients.
McMillan RA; Van Gompel JJ; Link MJ; Moore EJ; Price DL; Stokken JK; Van Abel KM; O'Byrne J; Giannini C; Chintakuntlawar A; Pinheiro Neto CD; Peris Celda M; Foote R; Choby G
Int Forum Allergy Rhinol; 2022 Dec; 12(12):1457-1467. PubMed ID: 35385606
[TBL] [Abstract][Full Text] [Related]
10. Neuroendocrine neoplasms of the sinonasal region.
Bell D; Hanna EY; Weber RS; DeMonte F; Triantafyllou A; Lewis JS; Cardesa A; Slootweg PJ; Stenman G; Gnepp DR; Devaney KO; Rodrigo JP; Rinaldo A; Wenig BM; Westra WH; Bishop JA; Hellquist H; Hunt JL; Kusafuka K; Perez-Ordoñez B; Williams MD; Takes RP; Ferlito A
Head Neck; 2016 Apr; 38 Suppl 1():E2259-66. PubMed ID: 26041714
[TBL] [Abstract][Full Text] [Related]
11. Esthesioneuroblastoma with distant metastases: Systematic review & meta-analysis.
Marinelli JP; Janus JR; Van Gompel JJ; Link MJ; Foote RL; Lohse CM; Price KA; Chintakuntlawar AV
Head Neck; 2018 Oct; 40(10):2295-2303. PubMed ID: 29756250
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical Profiling and Staging in Esthesioneuroblastoma: A Single-Center Cohort Study and Systematic Review.
Henson JC; Cutler CC; Cole KL; Lucke-Wold B; Khan M; Alt JA; Karsy M
World Neurosurg; 2023 Feb; 170():e652-e665. PubMed ID: 36435382
[TBL] [Abstract][Full Text] [Related]
13. Low- and high-grade esthesioneuroblastomas display a distinct natural history and outcome.
Malouf GG; Casiraghi O; Deutsch E; Guigay J; Temam S; Bourhis J
Eur J Cancer; 2013 Apr; 49(6):1324-34. PubMed ID: 23312882
[TBL] [Abstract][Full Text] [Related]
14. [Long-term experiences in the therapy of esthesioneuroblastoma].
Koch M; Constantinidis J; Dimmler A; Strauss C; Iro H
Laryngorhinootologie; 2006 Oct; 85(10):723-30. PubMed ID: 16673299
[TBL] [Abstract][Full Text] [Related]
15. Evaluating the prognostic potential of the Ki67 proliferation index and tumour-infiltrating lymphocytes in olfactory neuroblastoma.
Classe M; Burgess A; El Zein S; Wassef M; Herman P; Mortuaire G; Leroy X; Malouf GG; Verillaud B
Histopathology; 2019 Dec; 75(6):853-864. PubMed ID: 31306501
[TBL] [Abstract][Full Text] [Related]
16. Retropharyngeal lymph node metastasis from esthesioneuroblastoma: a review of the therapeutic and prognostic implications.
Zollinger LV; Wiggins RH; Cornelius RS; Phillips CD
AJNR Am J Neuroradiol; 2008 Sep; 29(8):1561-3. PubMed ID: 18499797
[TBL] [Abstract][Full Text] [Related]
17. [Pediatric esthesioneuroblastoma: an exceptional malignant lesion (a case study and literature review)].
Borni M; Kammoun B; Kolsi F; Boudawara MZ
Pan Afr Med J; 2018; 31():144. PubMed ID: 31037204
[TBL] [Abstract][Full Text] [Related]
18. Olfactory Neuroblastoma: Fate of the Neck--A Long-term Multicenter Retrospective Study.
Nalavenkata SB; Sacks R; Adappa ND; Palmer JN; Purkey MT; Feldman MD; Schlosser RJ; Snyderman CH; Wang EW; Woodworth BA; Smee R; Havas TE; Gallagher R; Harvey RJ
Otolaryngol Head Neck Surg; 2016 Feb; 154(2):383-9. PubMed ID: 26671900
[TBL] [Abstract][Full Text] [Related]
19. Sphenoid esthesioneuroblastoma arising from the hindmost olfactory filament.
Matsunaga M; Nakagawa T; Sakamoto T; Ito J
Auris Nasus Larynx; 2015 Apr; 42(2):170-2. PubMed ID: 25459497
[TBL] [Abstract][Full Text] [Related]
20. Esthesioneuroblastoma in children, adolescents and young adults.
Dumont B; Lemelle L; Cordero C; Couloigner V; Bernard S; Cardoen L; Brisse HJ; Jehanno N; Fréneaux P; Helfre S; Rouffiange L; Réguerre Y; Orbach D
Bull Cancer; 2020 Sep; 107(9):934-945. PubMed ID: 32896369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
